A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women

Trial Profile

A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs Dapivirine (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms The Ring Study
  • Most Recent Events

    • 26 Jul 2017 Pooled efficacy results of two independent well-controlled phase III trials of dapivirine vaginal ring (IPM 027 and MTN 020), presented at the 9th International AIDS Society Conference on HIV Science.
    • 14 Dec 2016 Status changed from recruiting to completed.
    • 07 Dec 2016 Status changed from active, no longer recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top